EULAR 2025, video met Arjen Stoppelenburg, UMCU en UU

June 2025

POS0743

Tolerogenic Dendritic Cells

TOLERANT Trial

Arjen Stoppelenburg

POS0743 – Harnessing Tolerogenic Dendritic Cells for Antigen-Specific Immune Modulation in Rheumatoid Arthritis: Findings from the TOLERANT Trial

Wilt u meer lezen? Log dan in.

Deel dit artikel

Inloggen

Vul alle velden in, om in te loggen

Onthoud mij!

Inloggen

Nog geen account? Schrijf u nu in.

Registreren

POS0431 – Drug free remission and the risk of involvement of new joints in early rheumatoid arthriti ...

POS0582 – Risk-Stratified Cost-Utility Analysis of the TREAT EARLIER Trial: One-Year Methotrexate Tr ...

POS0592 – Effectiveness of Tocilizumab vs Prednisone In Rheumatoid Arthritis Patients with Insuffici ...

POS0166 – Work-related physical strain is a novel risk factor for severity of inflamed joint tissues ...